Investigation of serum ischemia-modified albumin levels in coronary artery disease patients
- PMID: 33642712
- PMCID: PMC7876203
- DOI: 10.1007/s12055-020-01061-5
Investigation of serum ischemia-modified albumin levels in coronary artery disease patients
Abstract
Objective: Ischemia-modified albumin (IMA) is a novel marker for the detection of ischemia. The value of this biomarker has been studied in patients with coronary artery disease (CAD). However, the relationship between the severity of coronary stenosis and serum IMA levels remains unknown. Therefore, we aimed to investigate the potential role of serum IMA levels in predicting the severity of coronary atherosclerosis.
Materials and methods: One hundred and forty-two individuals who underwent coronary angiography for coronary artery disease complaints were included in the study. Participants were divided into three groups based on their diagnosis as control (healthy subjects), group I (subjects with lower Gensini score), and group II (subjects with higher Gensini score). Global Registry of Acute Coronary Events (GRACE) risk score and Gensini scores were calculated after coronary angiogram in the patient groups. Then, venous blood samples were collected from each participant. Serum IMA levels and the levels of routine laboratory markers were measured.
Results: The serum lymphocyte, neutrophil, and high-density lipid (HDL) levels were statistically insignificant between the groups. The white blood cell (WBC) count and IMA levels were significantly higher in the patient groups (p < 0.05). The GRACE and Gensini scores were significantly different in the patient groups (p < 0.05). However, there was no significant correlation between the GRACE and Gensini scores and serum IMA levels.
Conclusion: Although IMA levels can be a significant predictor for ischemia according to previous reports, this biomarker seems to be insufficient for determining the severity of disease in patients with CAD.
Keywords: Cardiovascular disease; Coronary artery disease; Disease severity.
© Indian Association of Cardiovascular-Thoracic Surgeons 2020.
Conflict of interest statement
Conflict of interestThe authors declare that they have no conflict of interest.
Similar articles
-
Ischemic Modified Albumin Predicts Critical Coronary Artery Disease in Unstable Angina Pectoris and Non-ST-Elevation Myocardial Infarction.J Clin Med Res. 2018 Jul;10(7):570-575. doi: 10.14740/jocmr3417w. Epub 2018 Jun 4. J Clin Med Res. 2018. PMID: 29904441 Free PMC article.
-
[N-terminal pro-brain natriuretic peptide (NT-proBNP) and ischemia modified albumin (IMA) in exercise induced ischemia in patients with stable coronary artery disease].Pol Arch Med Wewn. 2006 Jul;116(1):640-7. Pol Arch Med Wewn. 2006. PMID: 17340970 Polish.
-
Association between serum lipoprotein-associated phospholipase A2, ischemic modified albumin and acute coronary syndrome: a cross-sectional study.Heart Vessels. 2019 Oct;34(10):1608-1614. doi: 10.1007/s00380-019-01403-3. Epub 2019 Apr 8. Heart Vessels. 2019. PMID: 30963302
-
The Correlation Between Serum Fibroblast Growth Factor 21 and the Severity and Occurrence of Coronary Artery Disease.Cureus. 2024 Jan 9;16(1):e51924. doi: 10.7759/cureus.51924. eCollection 2024 Jan. Cureus. 2024. PMID: 38333506 Free PMC article.
-
Relationship between neutrophils to HDL-C ratio and severity of coronary stenosis.BMC Cardiovasc Disord. 2021 Mar 6;21(1):127. doi: 10.1186/s12872-020-01771-z. BMC Cardiovasc Disord. 2021. PMID: 33676400 Free PMC article.
Cited by
-
Correlation of Serum CysC, IMA, and LP-PLA2 Levels With Type 2 Diabetes Mellitus Patients With Lower Extremity Atherosclerotic Occlusive Disease.Front Surg. 2022 Mar 9;9:846470. doi: 10.3389/fsurg.2022.846470. eCollection 2022. Front Surg. 2022. PMID: 35356504 Free PMC article.
References
-
- Talwalkar SS, Bon Homme M, Miller JJ, Elin RJ. Ischemia modified albumin, a marker of acute ischemic events: a pilot study. Ann Clin Lab Sci. 2008;38:132–137. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous